R&D Spend Just One Problem for Lagging Portfolios
Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies....
Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies....
The orthopedic market finds itself in familiar territory in early 2022, with record COVID cases impacting elective surgery volumes....
Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will...
As we near 2Q earnings, we're watching for a barometer of the market's recovery, momentum in M&A as well as...
ORTHOWORLD’s newest installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT projects +14.6% growth in 2021 led by joint replacement and spine...
The first quarter of 2021 began amid COVID's deadliest surge. However, encouraging signs point toward a second half recovery....
We estimate the orthopedic market declined in the low single digits for 4Q20 and in the low double-digits for the...
The fourth quarter of 2020 brought a dramatic surge in the pandemic that further depressed orthopedic surgical volumes worldwide....
The orthopedic industry faced unique challenges and profound uncertainty in 2020. We recap market’s recovery through nine months and our...
While the orthopedic market recovered faster than expected in the second quarter, we saw indications of deceleration heading into the...
As a guest member you get access to more articles and videos every month.
We’ll send a recovery link to your email.
Return to Homepage